Tecentriq (atezolizumab) for the Treatment of Metastatic Urothelial Carcinoma (mUC) - Clinical Trials Arena
Safety and Clinical Activity of Atezolizumab Plus Ipilimumab in Locally Advanced or Metastatic Non–Small Cell Lung Cancer: Results From a Phase 1b Trial - ScienceDirect
Clinical Activity and Safety of Atezolizumab in a Phase 1 Study of Patients With Relapsed/Refractory Small-Cell Lung Cancer - ScienceDirect
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma | NEJM
Profile of atezolizumab in the treatment of metastatic non-small-cell | DDDT
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial - The Lancet
Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC | NEJM
Overview of listed clinical trials for Atezolizumab, Nivolumab, and... | Download Scientific Diagram
Selection of ongoing trials of pembrolizumab or atezolizumab in TNBC... | Download Scientific Diagram
IMpower150, IMpower110, & OAK Clinical Trial Designs | TECENTRIQ® ( atezolizumab)
Ongoing clinical trials with PD-L1 inhibitors in multiple myeloma... | Download Table
Atezolizumab for Urinary Bladder Cancer Clinical Trial | Power
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial - Clinical Lung Cancer
Atezolizumab - Wikipedia
History of PD-1 research. Abbreviations: FIM, first in man; approved,... | Download Scientific Diagram
Neoadjuvant atezolizumab and chemotherapy in patients with resectable non-small-cell lung cancer: an open-label, multicentre, single-arm, phase 2 trial - The Lancet Oncology
Smoking and immunotherapy efficacy in lung cancer by PDL1 subgroups: An individual participant data meta-analysis of atezolizumab clinical trials - European Journal of Cancer
IMPower133 Clinical Trial Design for ES-SCLC | TECENTRIQ® (atezolizumab)
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous NSCLC (IMpower131): Results From a Randomized Phase III Trial - Journal of Thoracic Oncology
Atezolizumab plus Bevacizumab combination therapy compared to Sorafenib and Atezolizumab monotherapies for treatment of unresectable or metastatic hepatocellular carcinoma - Asian Pacific Digestive Week 2021 | Kuala Lumpur
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial - The Lancet
S1929: Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients With SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC) - University of Illinois Cancer Center
Ongoing trials of atezolizumab in NSCLC | Download Table
IMpower150, IMpower110, & OAK Clinical Trial Designs | TECENTRIQ® ( atezolizumab)
